Tumor-Infiltrating Lymphocytes Up PFS in Advanced Melanoma
Significantly longer progression-free survival seen with infusion of tumor-infiltrating lymphocytes versus ipilimumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.